Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 1 of 123
`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 1 of 123
`
`
`
`
`
`
`
`
`
`APPENDIX E
`APPENDIX E
`
`
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 2 of 123
`
`APPENDIX E
`
`DEFENDANT BLUE COAT SYSTEMS LLC’S DESIGNATION OF DISCOVERY
`RESPONSES AND DEPOSITION DESIGNATIONS
`
`United States District Court
`For the Northern District of California (San Jose Division)
`
`Finjan, Inc. v. Blue Coat Systems LLC
`
`Case No. 15-cv-03295-BLF
`
`Trial Date: October 27, 2017
`
`Pursuant to Section C.3 of the Court’s Standing Order Re Final Pretrial Conference –
`
`Jury Trial, Defendant Blue Coat Systems LLC (“Blue Coat”) identifies the following discovery
`
`responses and deposition designations it may use at trial.
`
`Blue Coat reserves all rights, including its right to amend, modify, or supplement the
`
`following designations as trial preparation and trial progresses, to call witnesses live, by
`
`deposition, or both, and to use additional segments of depositions for impeachment, rebuttal,
`
`foundation, or other purposes.
`
`Blue Coat disputes Finjan’s objections, as stated in the column titled “Blue Coat’s
`
`Response.” Blue Coat has designated discovery and deposition testimony that is admissible,
`
`more probative than prejudicial, and directly relevant to issues in the case.
`
`
`
`1
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 3 of 123
`
`APPENDIX E
`
`Finjan’s General Objections
`
`Finjan objects to all of Blue Coat’s Trial Exhibits, deposition transcript designations, and
`
`
`
`discovery response designations to the extent they are precluded by a pending motion, i.e.
`
`motions in limine, Daubert motion, motion to strike, or issue identified in the Pretrial Statement
`
`or at the forthcoming Pretrial Conference. Finjan objects to all of Joint exhibits are noted as
`
`“JOINT.” Descriptions for these exhibits are found in the Joint Exhibit List at Appendix C-1.
`
`Finjan reserves its right to further object to these exhibits based on any changes made to the Joint
`
`Exhibit List. To the extent any exhibits are introduced for issues outside the scope of the
`
`October 30, 2017 trial, Finjan reserves the right to assert additional objections at trial. Finjan
`
`further reserves the right to assert additional objections at the time that Blue Coat introduces the
`
`proposed exhibits or testimony at trial depending on Blue Coat’s ability to properly authenticate,
`
`lay the proper foundation and demonstrate the intended use for the admission of the proposed
`
`exhibits, discovery responses and/or testimony into evidence.
`
`Finjan’s counter-designations apply to each of Blue Coat’s designations. Finjan
`
`incorporates by reference all objections stated by counsel in the deposition transcript in its
`
`objections to Blue Coat’s designations. Finjan reserves all objections to designated testimony
`
`that is incomplete or contains errors in the designation. Finjan reserves the right to rely upon
`
`Blue Coat’s designations to the extent that Blue Coat withdraws any of its designations. Finjan
`
`specifically objects to Blue Coat’s designation of trial testimony from Finjan v. Blue Coat, Case
`
`No. 13-3999, as hearsay that does not fall under the exceptions of Fed. R. Evid. 803 and 804.
`
`Finjan objects to Blue Coat’s statement that it “reserves all rights, including its right to amend,
`
`modify, or supplement the following designations as trial preparation and trial progresses, to call
`
`witnesses live, by deposition, or both, and to use additional segments of depositions for
`
`2
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 4 of 123
`
`APPENDIX E
`
`impeachment, rebuttal, foundation, or other purposes” as such a broad statement does not
`
`provide sufficient notice of Blue Coat’s pretrial disclosures and violates the Court’s Standing
`
`Order, Local Rules of the Court, the Federal Rules of Civil Procedure and/or Federal Rules of
`
`Evidence.
`
`
`
`Plaintiff Finjan, Inc.’s Key of Objections
`
`Objection List
`Hearsay (FRE 801, 802)—The exhibits/testimony are hearsay and do not fall
`within any hearsay exception.
`Irrelevant (FRE 401, 402)—The exhibits/testimony are inadmissible without any
`tendency to make the existence of any fact that is of consequence to the
`determination of the action more or less probable than it would be without them.
`Finjan notes this objection is used for the purpose for which Blue Coat offers the
`exhibit without waiving the right to use the exhibit or evidence for another
`purpose.
`Unfair Prejudice, Confusing, Waste of Time (403) —To the extent that these
`exhibits/testimony contain any relevant information, they should be excluded
`because their probative value is substantially outweighed by the danger of unfair
`prejudice, confusion of issues, or is a mischaracterization of the testimony, or
`misleading the jury, or by considerations of undue delay, waste of time, or
`needless presentation of cumulative evidence.
`Violates FRE 401, 402 and 403
`Lack of Personal Knowledge/Foundation (FRE 602)—Defendant has not
`identified a witness with personal knowledge to testify regarding these exhibits.
`The witness does not have personal knowledge to testify about a matter, the
`proposed testimony is speculation and/or outside the scope of the 30(b)(6)
`designation.
`Improper Lay Opinion (FRE 701)—The exhibits/testimony necessarily rely upon
`the opinion testimony of a lay witness beyond the scope of what is permitted.
`Improper Expert Opinion / Testimony (FRE 702)
`Authenticity—These exhibits have not been authenticated within the meaning of
`FRE 901. The testimony fails to authenticate the deposition exhibit.
`Best Evidence (FRE 1001-1003)—The exhibits/testimony fail to satisfy the best
`evidence rule under FRE 1001-1003.
`FRE 1006—These exhibits are an improper summary, chart, or calculation.
`Privilege (501)
`Improper Character Evidence (404, 608, 609)
`
`Abbreviation
`
`H
`
`401, 402
`
`403
`401-403
`
`602
`
`701
`702
`
`901
`
`1001-1003
`1006
`501
`CE
`
`3
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 5 of 123
`
`APPENDIX E
`
`Objection List
`Leading/Waste of Time (611)—The presentation of these exhibits/testimony will
`result in needless consumption of time and cause witnesses harassment or undue
`embarrassment. Leading questions should not be used on direct examination of a
`witness except as may be necessary to develop a witness’ testimony.
`Compound, Vague, Argumentative, Duplicative, Asked and Answered—The
`presentation of these exhibits/testimony violate FRE 403 and 611.
`Improper Legal Conclusion (401, 611)
`Subject to motion in limine and/or evidentiary dispute raised in the Pretrial
`Statement
`Not Related—Counter Designation is Not Related to Initial Designations
`Documents Not Produced During Discovery
`Multiple documents are listed as a single exhibit
`Incomplete/unintelligible document or testimony
`Not Testimony
`
`
`Abbreviation
`
`611
`
`403, 611
`LC
`
`EXC
`NR
`NP
`MD
`IC
`NT
`
`4
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 6 of 123
`
`APPENDIX E
`
`Defendant Blue Coat Systems LLC’s Response to
`Plaintiff Finjan, Inc.’s General Objections
`Blue Coat objects that Finjan’s statement that “Finjan’s counter-designations apply to
`
`each of Blue Coat’s designations” is an improper counter-designation under the Court’s Standing
`
`Order, Local Rules of the Court, the Federal Rules of Civil Procedure and/or Federal Rules of
`
`Evidence..
`
`
`Abbreviation
`C
`REL
`F
`
`LAY
`EXPERT
`NH
`AUTH
`BEST
`SUM
`AVAIL
`
`OPP
`FACT
`PROD
`IMPOBJ
`IMPRC
`
`
`
`Defendant Blue Coat Systems LLC’s Key of Responses
`
`Responses
`Complete
`Relevant, not unfairly prejudicial, confusing, or waste of time
`Will be used with witness with personal knowledge or 30(b)(6) deponent, or
`relied upon by expert
`Proper lay testimony, not submitted as expert testimony
`Proper expert testimony
`Not hearsay or qualifies as an exception to hearsay
`Properly authenticated or subject to stipulation re authentication
`Best evidence
`Proper summary
`Produced, publicly available and identified in deposition or expert report, or
`exchanged
`Subject to opposition to motion in limine
`Not a legal conclusion
`Produced during fact discovery or supplemented at request of Plaintiff
`Improper objection
`Improper counter-designation
`
`5
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 7 of 123
`
`APPENDIX E
`
`I.
`
`BLUE COAT’S DISCOVERY DESIGNATIONS
`
`Date
`
`09/21/2016
`
`Finjan’s
`Objections
`
`H, 1001-1003,
`IC, 401-403,
`NT
`
`Blue Coat’s
`Response
`
`NH, C, REL,
`IMPOBJ:
`1001-1003,
`NT
`
`09/21/2016
`
`H, 1001-1003,
`401-403, NT
`
`11/18/2016
`
`H, 1001-1003,
`401-403, NT
`
`11/18/2016
`
`H, 1001-1003,
`401-403, 611,
`NT
`
`11/18/2016
`
`H, 1001-1003,
`401-403, 611,
`NT
`
`NH, REL,
`IMPOBJ:
`1001-1003,
`NT
`
`NH, REL,
`IMPOBJ:
`1001-1003,
`NT
`
`NH, REL,
`IMPOBJ:
`1001-1003,
`611, NT
`
`NH, REL,
`IMPOBJ:
`1001-1003,
`611, NT
`
`11/18/2016
`02/17/2017
`
`H, 1001-1003,
`IC, 401-403,
`NT
`
`NH, C, REL,
`IMPOBJ:
`1001-1003,
`NT
`
`
`Discovery Responses
`
`Plaintiff Finjan, Inc.’s
`Objections and Responses
`to Defendant Blue Coat
`Systems, Inc.’s
`Interrogatories (Nos. 1-14)
`Plaintiff Finjan, Inc.’s
`Objections and Responses
`to Defendant Blue Coat
`Systems, Inc.’s
`Interrogatories (Nos. 1-14)
`Plaintiff Finjan, Inc.’s First
`Supplemental Objections
`and Responses to Defendant
`Blue Coat Systems, Inc.’s
`Interrogatories (Nos. 4, 5, 9,
`and 11)
`Plaintiff Finjan, Inc.’s First
`Supplemental Objections
`and Responses to Defendant
`Blue Coat Systems, Inc.’s
`Interrogatories (Nos. 4, 5, 9,
`and 11)
`Plaintiff Finjan, Inc.’s First
`Supplemental Objections
`and Responses to Defendant
`Blue Coat Systems, Inc.’s
`Interrogatories (Nos. 4, 5, 9,
`and 11)
`Plaintiff Finjan, Inc.’s
`Supplemental Objections
`and Responses to Defendant
`Blue Coat Systems, Inc.’s
`First Set of Interrogatories
`(Nos. 1-3, 7-9, and 11-13)
`
`Blue Coat’s
`Designated
`Portion
`Response to
`Interrogatory
`No. 3, page 12,
`lines 10-27
`
`Response to
`Interrogatory
`No. 4, page 16,
`lines 6-9
`
`Supplemental
`Response to
`Interrogatory
`No. 4, page 9,
`lines 17-27
`
`Supplemental
`Response to
`Interrogatory
`No. 5, page 11,
`lines20-23
`
`First
`Supplemental
`Response to
`Interrogatory
`No. 9
`
`First
`Supplemental
`Response to
`Interrogatory
`No. 9, page 13,
`lines 9-17 / see
`also Second
`Supplemental
`Response at
`page 36, lines
`3-11
`
`6
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 8 of 123
`
`APPENDIX E
`
`Discovery Responses
`
`Defendant Blue Coat
`Systems LLC’s Responses
`to Plaintiff Finjan, Inc.’s
`Third Set of Interrogatories
`(Nos. 7-10)
`Defendant Blue Coat
`Systems LLC’s
`Supplemental Responses to
`Plaintiff Finjan, Inc.’s Third
`Set of Interrogatories (No.
`8)
`Defendant Blue Coat
`Systems LLC’s Corrected
`Supplemental Response and
`Second Supplemental
`Response to Plaintiff Finjan,
`Inc.’s Third Set of
`Interrogatories (No. 8)
`Defendant Blue Coat
`Systems LLC’s Corrected
`Supplemental Response and
`Second Supplemental
`Response to Plaintiff Finjan,
`Inc.’s Third Set of
`Interrogatories (No. 8)
`Defendant Blue Coat
`Systems LLC’s Third
`Supplemental Response to
`Plaintiff Finjan, Inc.’s Third
`Set of Interrogatories (Nos.
`8-9)
`Defendant Blue Coat
`Systems LLC’s Fourth
`Supplemental Response to
`Plaintiff Finjan, Inc.’s Third
`Set of Interrogatories (No.
`8)
`Plaintiff Finjan, Inc.’s
`Objections and Responses
`to Defendant Blue Coat
`Systems LLC’s Requests for
`Admission (Nos. 1-50)
`
`Blue Coat’s
`Designated
`Portion
`Response to
`Interrogatory
`No. 8
`
`Supplemental
`Response to
`Interrogatory
`No. 8
`
`Corrected
`Supplemental
`Response to
`Interrogatory
`No. 8
`
`Second
`Supplemental
`Response to
`Interrogatory
`No. 8
`
`Third
`Supplemental
`Response to
`Interrogatory
`No. 8
`
`Fourth
`Supplemental
`Response to
`Interrogatory
`No. 8
`
`Response to
`Requests for
`Admission No.
`4
`
`Date
`
`Finjan’s
`Objections
`
`Blue Coat’s
`Response
`
`11/25/2016
`
`01/18/2017
`
`02/15/2017
`
`02/15/2017
`
`02/17/2017
`
`03/03/2017
`
`H, 1001-1003,
`401-403, 611,
`LC, 602, NT
`
`H, 1001-1003,
`401-403, 611,
`LC, 602, 1006,
`NT, NP
`
`H, 1001-1003,
`401-403, 611,
`LC, 602, 1006,
`NT, NP
`
`H, 1001-1003,
`401-403, 611,
`LC, 602, 1006,
`NT, NP
`
`H, 1001-1003,
`401-403, 611,
`LC, 602, 1006,
`NT, NP
`
`H, 1001-1003,
`401-403, 611,
`LC, 602, 1006,
`NT, NP
`
`02/17/2017
`
`H, 401-403,
`611, LC, NT
`
`NH, REL, F,
`FACT,
`IMPOBJ:
`1001-1003,
`611, NT
`NH, REL, F,
`FACT, PROD,
`IMPOBJ:
`1001-1003,
`611, NT
`
`NH, REL, F,
`FACT, PROD,
`IMPOBJ:
`1001-1003,
`611, NT
`
`NH, REL, F,
`FACT, PROD,
`IMPOBJ:
`1001-1003,
`611, NT
`
`NH, REL, F,
`FACT, PROD,
`IMPOBJ:
`1001-1003,
`611, NT
`
`NH, REL, F,
`FACT, PROD,
`IMPOBJ:
`1001-1003,
`611, NT
`
`NH, REL,
`FACT,
`IMPROP: 611,
`NT
`
`7
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 9 of 123
`
`APPENDIX E
`
`Discovery Responses
`
`Plaintiff Finjan, Inc.’s
`Objections and Responses
`to Defendant Blue Coat
`Systems LLC’s Requests for
`Admission (Nos. 1-50)
`Defendant Blue Systems
`LLC’s Responses and
`Objections to Plaintiff
`Finjan, Inc.’s First Set of
`Requests for Admission
`(Nos. 1-36)
`
`
`Blue Coat’s
`Designated
`Portion
`Response to
`Requests for
`Admission No.
`7
`
`Responses to
`Requests for
`Admission Nos.
`24, 25, 27-30
`
`Date
`
`02/17/2017
`
`Finjan’s
`Objections
`
`H, 401-403,
`611, NT
`
`02/13/2017
`
`H, 401-403,
`602, 611, LC,
`1001-1003, NT
`
`Blue Coat’s
`Response
`
`NH, REL,
`IMPROP: 611,
`NT
`
`NH, REL, F,
`FACT,
`IPROBJ: 611,
`1001-1003,
`NT
`
`8
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 10 of 123
`
`APPENDIX E
`
`II.
`
`BLUE COAT’S DEPOSITION DESIGNATIONS
`
`
`Bjorn Andersen (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`5:3-5:15
`18:25-19:1
`19:4-19:4
`19:9-19:19
`19:22-20:8
`20:10-20:22
`20:25-21:3
`21:6-21:7
`27:12-27:13
`
`
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`
`27:16-27:16
`
`401-403, IC
`
`29:3-29:11
`
`30:8-30:11
`
`32:5-32:17
`
`401-403, IC
`
`401-403, IC
`
`401-403, IC
`
`33:18-33:23
`
`401-403, IC
`
`37:1-37:13
`
`401-403, IC
`
`Finjan’s Counter-
`Designations
`
`
`26:3-17
`26:3-17
`26:3-17
`26:3-17
`26:3-17
`26:3-17
`26:3-17
`26:3-17; 28:25-29:2;
`29:12-30:7
`26:3-17; 28:25-29:2;
`29:12-30:7
`26:3-17; 28:25-29:2;
`29:12-30:7
`26:3-17; 28:25-29:2;
`29:12-30:7
`31:19-32:4; 32:18-
`33:17; 33:24-34:3
`31:19-32:4; 32:18-
`33:17; 33:24-34:3
`37:14-38:19
`
`41:13-41:14
`
`401-403, IC
`
`41:16-41:17
`
`401-403, IC
`
`41:18-42:1
`
`41:18-42:1
`
`46:21-46:22
`
`401-403, IC
`
`46:17-20; 46:25-47:19
`
`
`
`9
`
`Blue Coat’s Objections
`to Counter-
`Designations
`
`IMPRC
`IMPRC
`IMPRC
`IMPRC
`IMPRC
`IMPRC
`IMPRC
`IMPRC, FRE 403
`
`IMPRC, FRE 403
`
`FRE 403
`
`FRE 403
`
`FRE 402, FRE 403,
`IMPRC
`FRE 402, FRE 403
`
`IMPRC, asked and
`answered,
`mischaracterizes
`testimony
`FRE 402, asked and
`answered
`FRE 402, asked and
`answered
`IMPRC, vague, FRE
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 11 of 123
`
`APPENDIX E
`
`Bjorn Andersen (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`Finjan’s Counter-
`Designations
`
`46:24-46:24
`
`401-403, IC
`
`46:17-20; 46:25-47:19
`
`49:22-49:22
`
`401-403, IC
`
`50:1-51:17
`
`49:25-49:25
`
`401-403, IC
`
`50:1-51:17
`
`66:18-66:24
`
`401-403, IC
`
`66:25-69:13; 69:20-
`70:2; 70:13-24
`
`69:14-69:19
`
`401-403, IC
`
`66:25-69:13; 69:20-
`70:2; 70:13-24
`
`70:3-70:5
`
`401-403, IC
`
`66:25-69:13; 69:20-
`70:2; 70:13-24
`
`70:8-70:12
`
`401-403, IC
`
`66:25-69:13; 69:20-
`70:2; 70:13-24
`
`
`
`10
`
`Blue Coat’s Objections
`to Counter-
`Designations
`701, FRE 403
`IMPRC, vague, FRE
`701, FRE 403
`Vague, calls for
`narrative, incomplete
`hypothetical, FRE 403
`Vague, calls for
`narrative, incomplete
`hypothetical, FRE 403
`IMPRC,
`mischaracterizes prior
`testimony, vague,
`assumes facts not in
`evidence, calls for
`speculation, incomplete
`hypothetical, FRE 602,
`FRE 403, FRE 701
`IMPRC,
`mischaracterizes prior
`testimony, vague,
`assumes facts not in
`evidence, calls for
`speculation, incomplete
`hypothetical, FRE 602,
`FRE 403, FRE 701
`IMPRC,
`mischaracterizes prior
`testimony, vague,
`assumes facts not in
`evidence, calls for
`speculation, incomplete
`hypothetical, FRE 602,
`FRE 403, FRE 701
`IMPRC,
`mischaracterizes prior
`testimony, vague,
`assumes facts not in
`evidence, calls for
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 12 of 123
`
`APPENDIX E
`
`Bjorn Andersen (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`70:25-71:3
`
`401-403, IC
`
`71:7-71:9
`
`401-403, IC
`
`74:7-74:14
`
`401-403, IC
`
`75:14-75:18
`
`401-403, IC
`
`76:9-76:13
`
`401-403, IC
`
`88:6-88:17
`91:18-91:22
`101:7-101:20
`
`401-403, IC
`401-403, IC
`401-403, 602, IC
`
`101:22-101:24
`
`401-403, 602, IC
`
`
`
`11
`
`Finjan’s Counter-
`Designations
`
`66:25-69:13; 69:20-
`70:2; 70:13-24
`
`66:25-69:13; 69:20-
`70:2; 70:13-24
`
`Blue Coat’s Objections
`to Counter-
`Designations
`speculation, incomplete
`hypothetical, FRE 602,
`FRE 403, FRE 701
`IMPRC,
`mischaracterizes prior
`testimony, vague,
`assumes facts not in
`evidence, calls for
`speculation, incomplete
`hypothetical, FRE 602,
`FRE 403, FRE 701
`IMPRC,
`mischaracterizes prior
`testimony, vague,
`assumes facts not in
`evidence, calls for
`speculation, incomplete
`hypothetical, FRE 602,
`FRE 403, FRE 701
`Asked and answered,
`mischaracterizes prior
`testimony, FRE 403
`Asked and answered,
`mischaracterizes prior
`testimony, FRE 403
`Asked and answered,
`mischaracterizes prior
`testimony, FRE 403
`FRE 403
`
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`102:15-104:9; 105:20- FRE 402, FRE 403,
`
`74:15-75:13; 76:6-8;
`76:14-24
`
`74:15-75:13; 76:6-8;
`76:14-24
`
`74:15-75:13; 76:6-8;
`76:14-24
`
`87:11-88:5
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 13 of 123
`
`APPENDIX E
`
`Bjorn Andersen (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`102:2-102:14
`
`401-403, 602, IC
`
`104:19-105:9
`
`401-403, 602, IC
`
`105:11-105:19
`
`401-403, 602, IC
`
`106:1-106:2
`
`401-403, 602, IC
`
`106:6-106:11
`
`401-403, 602, IC
`
`107:4-107:13
`
`401-403, 602, IC
`
`
`
`12
`
`Finjan’s Counter-
`Designations
`
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`
`Blue Coat’s Objections
`to Counter-
`Designations
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 14 of 123
`
`APPENDIX E
`
`Bjorn Andersen (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`107:16-107:20
`
`401-403, 602, IC
`
`108:17-108:20
`
`401-403, 602, IC
`
`109:17-109:20
`
`401-403, 602, IC
`
`109:23-110:3
`
`401-403, 602, IC
`
`110:21-111:12
`
`401-403, 602, IC
`
`115:3-115:10
`
`401-403, IC
`
`
`
`13
`
`Finjan’s Counter-
`Designations
`
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`Blue Coat’s Objections
`to Counter-
`Designations
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 15 of 123
`
`APPENDIX E
`
`Bjorn Andersen (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`Finjan’s Counter-
`Designations
`
`116:4-116:20
`
`401-403, IC
`
`401-403, IC
`401-403, IC
`401-403, IC
`
`121:6-121:19
`121:15-121:22
`122:1-122:7
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`6:6-6:24
`
`7:1-7:21
`
`11:16-11:25
`12:14-12:14
`12:17-13:2
`13:5-13:10
`23:6-23:19
`
`401-403, IC
`
`401-403, IC
`
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`401-403, IC
`
`25:12-25:12
`
`401-403, IC
`
`102:15-104:9; 105:20-
`25; 107:21-108:16;
`108:21-109:16; 110:4-
`6; 111:13-23; 115:11-
`16; 116:21-24
`
`122:8-9
`122:8-9
`122:8-9
`
`Finjan’s Counter-
`Designations
`
`7:22-8:2
`
`7:22-8:2
`
`12:1-13; 13:11-14
`12:1-13; 13:11-14
`12:1-13; 13:11-14
`12:1-13; 13:11-14
`23:20-24:20
`
`17:6-9; 25:4-11; 26:2-
`15; 26:2-15; 26:18-7;
`27:13-28:15
`
`25:15-25:17
`
`401-403, IC
`
`17:6-9; 25:4-11; 26:2-
`
`
`
`14
`
`Blue Coat’s Objections
`to Counter-
`Designations
`argumentative, IMPRC
`FRE 402, FRE 403,
`assumes facts,
`mischaracterizes prior
`testimony, vague, asked
`and answered,
`argumentative, IMPRC
`FRE 403
`FRE 403
`FRE 403
`
`Blue Coat’s Objections
`to Counter-
`Designations
`Vague, calls for a
`narrative, IMPRC
`Vague, calls for a
`narrative
`
`
`
`
`FRE 403, vague, calls
`for speculation
`IMPRC, FRE 602, FRE
`403, calls for
`speculation, vague,
`outside the 30(b)(6)
`scope, mischaracterizes
`prior testimony, asked
`and answered
`IMPRC, FRE 602, FRE
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 16 of 123
`
`APPENDIX E
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`26:16-26:17
`
`401-403, 602 IC
`
`27:8-27:9
`
`401-403, 602 IC
`
`27:12-27:12
`
`401-403, 602 IC
`
`Finjan’s Counter-
`Designations
`
`15; 26:2-15; 26:18-7;
`27:13-28:15
`
`17:6-9; 25:4-11; 26:2-
`15; 26:2-15; 26:18-7;
`27:13-28:15-7
`
`17:6-9; 25:4-11; 26:2-
`15; 26:2-15; 26:18-7;
`27:13-28:15
`
`17:6-9; 25:4-11; 26:2-
`15; 26:2-15; 26:18-7;
`27:13-28:15
`
`44:25-45:2
`
`401-403, IC
`
`34:18-35:2; 42:1-4;
`43:25-44:24; 45:7-15
`
`45:4-45:6
`
`401-403, IC
`
`34:18-35:2; 42:1-4;
`43:25-44:24; 45:7-15
`
`
`
`15
`
`Blue Coat’s Objections
`to Counter-
`Designations
`403, calls for
`speculation, vague,
`outside the 30(b)(6)
`scope, mischaracterizes
`prior testimony, asked
`and answered
`IMPRC, FRE 602, FRE
`403, calls for
`speculation, vague,
`outside the 30(b)(6)
`scope, mischaracterizes
`prior testimony, asked
`and answered
`IMPRC, FRE 602, FRE
`403, calls for
`speculation, vague,
`outside the 30(b)(6)
`scope, mischaracterizes
`prior testimony, asked
`and answered
`IMPRC, FRE 602, FRE
`403, calls for
`speculation, vague,
`outside the 30(b)(6)
`scope, mischaracterizes
`prior testimony, asked
`and answered
`FRE 602, FRE 403,
`vague, calls for
`speculation,
`mischaracterizes prior
`testimony, incomplete
`hypothetical
`FRE 602, FRE 403,
`vague, calls for
`speculation,
`mischaracterizes prior
`testimony, incomplete
`hypothetical
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 17 of 123
`
`APPENDIX E
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`Finjan’s Counter-
`Designations
`
`52:11-52:19
`52:22-53:15
`54:1-55:1
`61:14-62:6
`62:8-62:10
`69:12-69:23
`
`401-403, 602 IC
`401-403, 602 IC
`401-403, 602 IC
`401-403, 602 IC
`401-403, 602 IC
`401-403, IC
`
`69:25-71:11
`
`401-403, IC
`
`71:14-71:19
`
`401-403, IC
`
`71:23-72:5
`
`72:7-72:18
`
`401-403, IC
`
`401-403, IC
`
`72:20-72:23
`
`401-403, IC
`
`53:16-17
`53:16-17
`62:11-15
`62:11-15
`62:11-15
`68:10-69:11
`
`68:10-69:11
`
`68:10-69:11
`
`68:10-69:11
`
`68:10-69:11
`
`68:10-69:11
`
`79:22-80:2
`
`401-403, 602, IC
`
`86:6-18
`
`80:6-80:7
`
`401-403, 602, IC
`
`86:6-18
`
`81:21-82:7
`
`401-403, 602, IC
`
`86:6-18
`
`82:10-83:7
`
`401-403, 602, IC
`
`86:6-18
`
`83:8-83:18
`
`401-403, 602, IC
`
`86:6-18
`
`
`
`16
`
`Blue Coat’s Objections
`to Counter-
`Designations
`FRE 403
`FRE 403
`
`
`
`Vague, calls for
`speculation
`Vague, calls for
`speculation
`Vague, calls for
`speculation
`Vague, calls for
`speculation
`Vague, calls for
`speculation
`Vague, calls for
`speculation
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 18 of 123
`
`APPENDIX E
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`Finjan’s Counter-
`Designations
`
`83:22-84:5
`
`401-403, 602, IC
`
`86:6-18
`
`84:7-85:4
`
`401-403, 602, IC
`
`86:6-18
`
`85:7-86:5
`
`401-403, 602, IC
`
`86:6-18
`
`91:20-92:7
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`93:20-95:3
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`95:6-95:19
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`95:20-96:6
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`96:9-96:19
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`
`
`17
`
`Blue Coat’s Objections
`to Counter-
`Designations
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 403, FRE 402,
`vague, calls for
`speculation, incomplete
`hypothetical, FRE 602
`FRE 402, FRE 403,
`FRE 602, vague, calls
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`FRE 602, vague, calls
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`FRE 602, vague, calls
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`FRE 602, vague, calls
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`FRE 602, vague, calls
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 19 of 123
`
`APPENDIX E
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`Finjan’s Counter-
`Designations
`
`96:14-96:21
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`96:25-97:3
`
`401-403, IC
`
`97:4-7; 97:10-98:6
`
`98:15-98:19
`
`401-403, IC
`
`99:21-99:23
`
`401-403, IC
`
`101:18-101:19
`
`401-403, IC
`
`101:22-102:1
`
`401-403, IC
`
`102:17-102:24
`
`401-403, IC
`
`102:23-102:24
`
`401-403, IC
`
`103:2-103:16
`
`401-403, IC
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`99:19-20; 99:24-
`101:14; 102:2-16
`
`114:25-115:3
`
`401-403, IC
`
`116:16-117:7
`
`
`
`18
`
`Blue Coat’s Objections
`to Counter-
`Designations
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`FRE 602, vague, calls
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`FRE 602, vague, calls
`for speculation,
`incomplete hypothetical,
`asked and answered
`FRE 402, FRE 403,
`vague, asked and
`answered, IMPRC
`FRE 402, FRE 403,
`vague, asked and
`answered, IMPRC
`FRE 402, FRE 403,
`vague, asked and
`answered, IMPRC
`FRE 402, FRE 403,
`vague, asked and
`answered
`FRE 402, FRE 403,
`vague, asked and
`answered, IMPRC
`FRE 402, FRE 403,
`vague, asked and
`answered, IMPRC
`FRE 402, FRE 403,
`vague, asked and
`answered, IMPRC
`FRE 402, FRE 403,
`IMPRC
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 20 of 123
`
`APPENDIX E
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`115:7-116:7
`
`401-403, IC
`
`116:10-116:15
`
`401-403, IC
`
`120:1-120:23
`122:21-123:14
`
`401-403, 602, IC
`401-403, IC
`
`124:2-124:12
`
`401-403, IC
`
`124:5-125:6
`
`401-403, IC
`
`124:15-125:6
`
`401-403, IC
`
`125:9-125:10
`
`401-403, IC
`
`125:9-126:3
`
`401-403, IC
`
`126:1-126:3
`
`401-403, IC
`
`
`
`19
`
`Finjan’s Counter-
`Designations
`
`116:16-117:7
`
`116:16-117:7
`
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`Blue Coat’s Objections
`to Counter-
`Designations
`FRE 402, FRE 403,
`IMPRC
`FRE 402, FRE 403,
`IMPRC
`
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 21 of 123
`
`APPENDIX E
`
`Christophe Birkeland (03/16/17)
`Blue Coat’s
`Finjan’s Objections
`Designations
`
`Finjan’s Counter-
`Designations
`
`126:6-126:17
`
`401-403, IC
`
`126:20-126:24
`
`401-403, IC
`
`133:6-133:9
`
`401-403, IC
`
`133:12-133:13
`
`401-403, IC
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`123:15-124:1; 128:1-
`133:5; 133:14-134:1
`
`Blue Coat’s Objections
`to Counter-
`Designations
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`Vague, asked and
`answered, calls for
`speculation, IMPRC,
`FRE 402, FRE 403,
`FRE 602
`
`
`Tom Clare (01/15/15)
`Blue Coat’s
`Designations
`
`Finjan’s Objections
`
`7:12-8:5
`
`401-403, 602, 611, IC, H
`
`10:13-11:23
`
`401-403, 602, 611, IC, H
`
`16:18-17:11
`
`401-403, 602, 611, IC, H
`
`
`
`20
`
`Finjan’s Counter-
`Designations
`
`8:6-10:12; 11:24-
`16:17; 17:12-23:8
`
`8:6-10:12; 11:24-
`16:17; 17:12-23:8
`
`8:6-10:12; 11:24-
`16:17; 17:12-23:8
`
`Blue Coat’s Objections
`to Counter-
`Designations
`IMPRC, FRE 602, FRE
`402, FRE 403, assumes
`facts, vague
`IMPRC, FRE 602, FRE
`402, FRE 403, assumes
`facts, vague
`IMPRC, FRE 602, FRE
`402, FRE 403, assumes
`
`

`

`Case 5:15-cv-03295-BLF Document 289-7 Filed 09/21/17 Page 22 of 123
`
`APPENDIX E
`
`Tom Clare (01/15/15)
`Blue Coat’s
`Designations
`
`Finjan’s Objections
`
`Finjan’s Counter-
`Designations
`
`23:9-23:12
`
`401-403, 602, 611, IC, H
`
`25:7-27:17; 30:19-23
`
`29:14-30:18
`
`401-403, 602, 611, IC, H
`
`25:7-27:17; 30:19-23
`
`30:24-31:2
`
`401-403, 602, 611, IC, H
`
`31:5-34:12; 35:14-22
`
`34:13-35:13
`
`401-403, 602, 611, IC, H
`
`31:5-34:12; 35:14-22
`
`36:6-36:25
`
`401